首頁 > 市場調查報告書 > 製藥

催產素市場規模、佔有率和成長分析（按適應症、通路、給藥途徑和地區分類）－2025-2032年產業預測

市場調查報告書

商品編碼

1865362

催產素市場規模、佔有率和成長分析（按適應症、通路、給藥途徑和地區分類）－2025-2032年產業預測

Oxytocin Market Size, Share, and Growth Analysis, By Indication (Antepartum, Postpartum), By Distribution Channel (Hospitals, Pharmacies), By Route of Administration, By Region - Industry Forecast 2025-2032

出版日期: 2025年11月07日 | 出版商:

SkyQuest | 英文 173 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2023 年，全球催產素市場規模將達到 41 億美元，到 2024 年將達到 43.1 億美元，到 2032 年將達到 64.2 億美元，預測期（2025-2032 年）的複合年成長率為 5.1%。

全球催產素市場正經歷顯著成長，主要促進因素是分娩併發症的增加以及發展中地區對孕產婦健康的日益重視。此外，人們對有效分娩管理的認知不斷提高，以及催產素在引產和產後出血治療中的應用日益廣泛，也進一步推動了市場需求。注射劑和滴鼻劑等創新給藥系統有助於提高藥物的可近性和患者滿意度。合成製劑和生物相似藥製劑的市場趨勢尤其顯著，它們在確保品質穩定的同時，最大限度地降低了污染風險。在亞太和非洲等地區，由於醫療基礎設施的改善和公眾意識的提高，人們對便捷給藥方式的需求日益成長。然而，市場面臨的挑戰包括嚴格的監管障礙、使用安全性方面的擔憂、遍遠地區獲取途徑有限、高成本以及來自其他催產藥物和草藥的競爭。

全球催產素市場促進因素

全球催產素市場的主要促進因素之一是催產素在各個醫療領域，特別是婦產科領域的應用日益廣泛。隨著醫療專業人員尋求有效應對分娩併發症的解決方案，催產素作為引產劑的需求持續成長。此外，人們越來越認知到催產素在治療產後出血和促進母乳哺育方面的作用，這也進一步推動了醫療專業人員對其的使用。母嬰健康意識的提高，以及醫療技術和實踐的進步，都顯著促進了全球催產素市場的擴張。

限制全球催產素市場的因素

全球催產素市場面臨的主要限制因素之一是監管挑戰和醫療監管機構嚴格的核准流程。這些法規通常要求進行大量的臨床試驗並提交大量文件以確保安全性和有效性，導致產品上市延遲，並增加製造商的成本。此外，催產素濫用和仿單標示外用藥的潛在風險也會阻礙該領域的投資和創新。而且，不同地區的法規差異也將使希望在全球範圍內拓展產品線的公司在打入市場策略和合規方面面臨諸多挑戰。

全球催產素市場趨勢

全球催產素市場正經歷著向合成製劑和生物相似藥製劑的顯著轉變，這主要受純度和濃度提升以及降低污染風險的趨勢所驅動。這一轉變源於對催產素產品安全性和品質的更高要求，旨在更有效地滿足全球醫療需求。這些進步不僅確保了療效的穩定性，也符合監管標準，從而促進了催產素在不同醫療環境中的廣泛應用和擴充性。這些創新使市場能夠在孕產婦健康和其他醫療應用領域提供更完善的治療方案，進一步鞏固了催產素作為全球重要藥物的地位。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2024 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2024 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2022-2024年營收年比比較

主要企業簡介

Novartis AG
Pfizer Inc.
Fresenius Kabi LLC
Ferring BV
Hikma Pharmaceuticals PLC
Endo International plc.（Par Sterile Products, LLC）
Teva Pharmaceutical Industries Ltd.
Mylan NV
Sun Pharmaceutical Industries Ltd.
Yuhan Corporation
Wockhardt Ltd.
Weefsel Pharma
EVER Pharma

結論與建議

簡介目錄

Product Code: SQMIG35I2465

Global Oxytocin Market size was valued at USD 4.1 billion in 2023 and is poised to grow from USD 4.31 billion in 2024 to USD 6.42 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The global oxytocin market is experiencing significant growth, primarily fueled by rising childbirth complications and an emphasis on maternal health in developing regions. Enhanced knowledge of effective labor management and the increased application of oxytocin for induction and postpartum hemorrhage treatment further boost demand. Innovative drug delivery systems, including injectables and nasal sprays, have improved accessibility and patient satisfaction. Trends indicate a shift towards synthetic and biosimilar formulations, offering consistent quality with minimized contamination risks. The growing inclination for convenient delivery methods aligns with rising healthcare infrastructure and awareness in regions like Asia-Pacific and Africa. However, market challenges include stringent regulatory hurdles, safety concerns over usage, limited rural accessibility, high costs, and competition from alternative labor-stimulation drugs and herbal remedies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oxytocin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oxytocin Market Segments Analysis

Global Oxytocin Market is segmented by Indication, Distribution Channel, Route of Administration and region. Based on Indication, the market is segmented into Antepartum and Postpartum. Based on Distribution Channel, the market is segmented into Hospitals, Pharmacies, Drug Stores and Online Pharmacies. Based on Route of Administration, the market is segmented into Parenteral, Intranasal and mucosal. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oxytocin Market

One of the key market drivers for the global oxytocin market is the increasing application of oxytocin in various medical fields, particularly in obstetrics and gynecology. As healthcare providers seek effective solutions for managing labor and delivery complications, the demand for oxytocin as a labor-inducing agent continues to rise. Additionally, its role in addressing postpartum hemorrhage and enhancing breastfeeding is gaining recognition, further bolstering its usage among healthcare professionals. The growing awareness of maternal and neonatal health, coupled with advancements in medical technologies and practices, significantly contributes to the expanding market for oxytocin globally.

Restraints in the Global Oxytocin Market

One of the key market restraints for the global oxytocin market is the regulatory challenges and stringent approval processes imposed by healthcare authorities. These regulations often require extensive clinical trials and documentation to ensure safety and efficacy, leading to delays in product launches and increased costs for manufacturers. Additionally, the potential for misuse and the associated risks of off-label use of oxytocin can deter investment and innovation within the sector. Furthermore, varying regulations across different regions can complicate market entry strategies and compliance for companies aiming to expand their product offerings globally.

Market Trends of the Global Oxytocin Market

The Global Oxytocin market is witnessing a notable shift toward synthetic and biosimilar formulations, favoring enhanced purity and concentration, alongside reduced contamination risks. This transition is driven by the demand for higher safety and quality in oxytocin products, addressing global health needs more effectively. Such advancements not only assure consistent efficacy but also align with regulatory standards, thus promoting wider accessibility and scalability in diverse healthcare settings. With these innovations, the market is poised to provide improved therapeutic options for maternal health and other medical applications, further solidifying oxytocin's role as a vital pharmaceutical product worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Oxytocin Market Size by Indication & CAGR (2025-2032)

Market Overview
Antepartum
Postpartum

Global Oxytocin Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Hospitals
Pharmacies
Drug Stores
Online Pharmacies

Global Oxytocin Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Parenteral
Intranasal
mucosal

Global Oxytocin Market Size & CAGR (2025-2032)

North America (Indication, Distribution Channel, Route of Administration)
- US
- Canada
Europe (Indication, Distribution Channel, Route of Administration)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Indication, Distribution Channel, Route of Administration)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Indication, Distribution Channel, Route of Administration)
- Brazil
- Rest of Latin America
Middle East & Africa (Indication, Distribution Channel, Route of Administration)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikma Pharmaceuticals PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo International plc. (Par Sterile Products, LLC)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Yuhan Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wockhardt Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Weefsel Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EVER Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments